Quarterly report pursuant to Section 13 or 15(d)

Note 4 - Capital Stock

Note 4 - Capital Stock
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Equity [Text Block]

Note 4 - Capital Stock


Holders of the common stock are entitled to receive such dividends as may be declared by the Board of Directors out of funds legally available therefor. To date no dividends have been declared. Upon dissolution and liquidation of the Company, holders of the common stock are entitled to a ratable share of the net assets of the Company remaining after payments to creditors of the Company. The holders of shares of common stock are entitled to one vote per share for the election of each director nominated to the Board and one vote per share on all other matters submitted to a vote of stockholders.


The Company’s amended and restated certificate of incorporation authorizes the Company to issue 40,000,000 shares of common stock with a par value of $0.001 per share.


Sales of Common Stock


On April 20, 2022, the Company entered into a Capital on Demand™ Sales Agreement with JonesTrading Institutional Services LLC (“JonesTrading”), pursuant to which Monopar may offer and sell, from time to time, through or to JonesTrading, as sales agent or principal, shares of Monopar’s common stock. On April 20, 2022, the Company filed a prospectus supplement with the U.S. Securities and Exchange Commission relating to the offer and sale of its common stock from time to time pursuant to the agreement up to an aggregate amount of $4,870,000. In addition, the Company filed a new Form S-3, which included therein a prospectus to increase the aggregate amount under this agreement to $6,505,642. The Form S-3 was declared effective by the Securities and Exchange Commission on January 4, 2023, at which time the prospectus included therein replaced the prior prospectus supplement. Expenses related to these financing activities were recorded as offering costs (a reduction of additional paid in capital) on the Company’s condensed consolidated statement of stockholders’ equity for the period. During the nine months ended September 30, 2023, the Company sold 1,125,479 shares of its common stock at an average gross price per share of $1.60 for net proceeds of $1,760,197, after fees and commissions of $45,161. In addition, the Company incurred and accrued legal, accounting and other fees totaling $27,241 for net proceeds after fees, commissions and expenses of $1,732,956. During the nine months ended September 30, 2022, the Company did not sell any shares of common stock.



As of September 30, 2023, the Company had 14,198,438 shares of common stock issued and outstanding.